hey Spike, each to their own. IMO the trial will be success albeit delayed. They are building their team and manufacturing facilities for a bigger trial. A company their size wouldn’t embark on hiring spree if they didn’t know the trial outcome. At the end of the day, directors have a duty of care towards the company. ie we now know 2 out of 3 things from the trial 1. Safe and well tolerated. 2. Reaches lymph nodes. 3. Detectable ? This is the missing piece. once this is answered favourably, strong uptrend will commence .so much they can do with this technology from their on like, other cancers as well as delivery of drugs to cancer cells ans leaving other cells alone.
IBX Price at posting:
5.7¢ Sentiment: Buy Disclosure: Held
